Showing 1 - 15 results of 15 for search 'T S Krolevets', query time: 0.04s Refine Results
  1. 1
    PROPERTIES OF NANO ENCAPSULATED L-ARGININE AND RESVERATROL IN WATER-SOLUBLE POLYMERS

    PROPERTIES OF NANO ENCAPSULATED L-ARGININE AND RESVERATROL IN WATER-SOLUBLE POLYMERS by Ilya Bogachev, Alexander Krolevets

    Published 2015-12-01
    Get full text
    Article
  2. 2
    The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease

    The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease by T. S. Krolevets, M. A. Livzan, S. I. Mozgovoy

    Published 2020-12-01
    Get full text
    Article
  3. 3
    COMPUTER PROGRAM OF REVEALING THE KAMCHATKA’S EARTHQUAKES HYPOCENTERS SPATIAL GROUPING PLANES

    COMPUTER PROGRAM OF REVEALING THE KAMCHATKA’S EARTHQUAKES HYPOCENTERS SPATIAL GROUPING PLANES by A.M. Makeev, A.N. Krolevets

    Published 2011-12-01
    Get full text
    Article
  4. 4
    Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease

    Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease by N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets

    Published 2020-09-01
    Get full text
    Article
  5. 5
    Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease

    Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease by N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets

    Published 2020-02-01
    Get full text
    Article
  6. 6
    Early disease detection expert system development: primary machining software applications and dependences

    Early disease detection expert system development: primary machining software applications and dependences by A. S. Serobabov, E. V. Chebanenko, L. A. Denisova, T. S. Krolevets

    Published 2018-09-01
    Get full text
    Article
  7. 7
    Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis

    Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis by S. I. Mozgovoi, M. A. Livzan, T. S. Krolevets, A. G. Shimanskaya

    Published 2020-01-01
    Get full text
    Article
  8. 8
    Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy

    Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy by A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets

    Published 2022-01-01
    Get full text
    Article
  9. 9
    Specific features of gastroesophageal reflux disease associated with obesity and overweight

    Specific features of gastroesophageal reflux disease associated with obesity and overweight by M A Livzan, I V Lapteva, T S Krolevets, I E Kiselev

    Published 2016-02-01
    Get full text
    Article
  10. 10
    PROPERTIES OF NANOSTRUCTURED CHIA SEEDS AND PROSPECTS OF THEIR APPLICATION IN FUNCTIONAL FOODSTUFFS

    PROPERTIES OF NANOSTRUCTURED CHIA SEEDS AND PROSPECTS OF THEIR APPLICATION IN FUNCTIONAL FOODSTUFFS by ALEXANDER A. KROLEVETS, NINA I. MYACHIKOVA, CECILIA GEORGESCU, VYACHESLAV S. ANDREENKOV

    Published 2019-03-01
    Get full text
    Article
  11. 11
    Leptin resistance in patients with nonalcoholic fatty liver disease associated with obesity and overweight

    Leptin resistance in patients with nonalcoholic fatty liver disease associated with obesity and overweight by M. A. Livzan, I. V. Lapteva, T. S. Krolevets, N. A. Cherkaschenko

    Published 2015-12-01
    Get full text
    Article
  12. 12
    Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver disease

    Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver disease by M. A. Livzan, T. S. Krolevets, S. I. Mozgovoy, N. A. Nikolaev, A. V. Nelidova

    Published 2021-02-01
    Get full text
    Article
  13. 13
    The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease

    The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease by M A Livzan, V A Akhmedov, T S Krolevets, O V Gaus, N A Cherkaschenko

    Published 2016-12-01
    Get full text
    Article
  14. 14
    Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease

    Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease by K. A. Andreev, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, A. V. Gorbenko, M. M. Fedorin, T. S. Krolevets

    Published 2022-01-01
    Get full text
    Article
  15. 15
    DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites

    DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites by Mykhailo Krolevets, Vincent ten Cate, Jürgen H. Prochaska, Andreas Schulz, Steffen Rapp, Stefan Tenzer, Miguel A. Andrade-Navarro, Steve Horvath, Christof Niehrs, Philipp S. Wild

    Published 2023-03-01
    Get full text
    Article

Search Tools: